GMM Pfaudler (505255) investor relations material

Executive summary

• Completed a major organizational transformation, shifting from regional to four global technology divisions (CRT, PPT, HET, PST) with dedicated leadership and accountability for technology, product, and customer engagement.

• Revenue grew 16% year-over-year to ₹925 crore, with EBITDA at ₹94 crore (down 7% YoY), and PAT at ₹23.90 crore (up over 100% YoY).

• Order intake reached ₹1,007 crore, flat YoY but up 16% QoQ, and backlog increased 20% YoY to ₹2,289 crore.

• Leadership team strengthened, with clear roles and succession planning to drive global mindset and performance alignment.

• Major orders secured in mining and petrochemical sectors, strengthening diversification.

Financial highlights

• Consolidated revenue for Q1 FY 2027 was ₹924.76 crore, up 16% year-on-year.

• EBITDA stood at ₹94 crore, down 7% YoY but up 25% sequentially; EBITDA margin was 10.1%, down from 12.7% YoY but up from 8.0% sequentially.

• Profit After Tax was ₹23.90 crore, more than doubling year-on-year; PAT margin improved to 2.4% from 1.3% YoY.

• Basic EPS rose 114% YoY to ₹5.32.

• Order backlog reached ₹2,289 crore, up 20% YoY and 4% QoQ, with most orders executable within FY 2027.

Outlook and guidance

• Management targets a minimum 15% EBITDA margin over the medium term, with ongoing initiatives to improve margins and cost structure.

• Margin improvement expected as underperforming units are addressed and integration synergies are realized.

• Positive momentum expected to continue, supported by a healthy order pipeline and strong backlog.

• Ongoing initiatives to reduce debt and optimize capital structure, with EUR 7 million debt repayment planned by Q2 FY27.

• Strong revenue visibility for FY 2027 due to robust order backlog and improving market conditions, especially in pharma.